Medical Properties Trust, Inc. (MPT)
NYSE: MPT · Real-Time Price · USD
4.530
+0.180 (4.14%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Medical Properties Trust Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Medical Properties Trust stock have an average target of 6.00, with a low estimate of 4.50 and a high estimate of 8.00. The average target predicts an increase of 32.45% from the current stock price of 4.53.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Medical Properties Trust stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $4.5 | Hold | Reiterates | $4.5 | -0.66% | Jun 18, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $8 | Buy | Reiterates | $8 | +76.60% | May 2, 2026 |
| Colliers Securities | Colliers Securities | Buy Maintains $7 → $6.5 | Buy | Maintains | $7 → $6.5 | +43.49% | Apr 30, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Sell Maintains $6 → $5 | Sell | Maintains | $6 → $5 | +10.38% | Mar 26, 2026 |
| KeyBanc | KeyBanc | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Feb 20, 2026 |
Financial Forecast
Revenue This Year
1.04B
from 1.07B
Decreased by -2.82%
Revenue Next Year
1.10B
from 1.04B
Increased by 5.58%
EPS This Year
0.11
EPS Next Year
0.15
from 0.11
Increased by 33.34%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.0B | 1.2B | |
| Avg | 1.0B | 1.1B | |
| Low | 1.0B | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.9% | 13.4% | |
| Avg | -2.8% | 5.6% | |
| Low | -3.4% | 0.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.11 | 0.18 | |
| Avg | 0.11 | 0.15 | |
| Low | 0.11 | 0.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 63.6% | |
| Avg | - | 33.3% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.